Nu Skin Enterprises (NUS) Slammed as Citron Says China Sales in Jeopardy on Violations

Nu Skin Enterprises Inc. (NYSE: NUS) has found itself the target of famed short-selling website Citron Research, and investor are already running for the hills.

Citron belieives Nu Skin Enterprises is violating "direct selling" rules in China, "and their entire Chinese business operation could be in jeopardy of seizure and other substantial risks."

"Nu Skin investors are exposed to the massive risk of its China operations coming to an abrupt halt due to violation of the PRC’s and Hong Kong pyramid sales laws. The consequences would be devastating," Citron concludes.

Shares of NUS are down 8.5 percent to $44.70 on the negative mention.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• B. Riley Financial (RILY) touching day low of $27, giving back half the day's gains
• AGBA Group Holding (AGBA) selling off into close, down over 17%